Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Allorhizobium taibaishanense CCNWSX 0483

ABSTRACT: Allorhizobium taibaishanense CCNWSX 0483 Genome sequencing

PROVIDER: PRJNA213176 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Allorhizobium sp.

Project description:Allorhizobium sonneratiae BGMRC 0089 Genome sequencing and assembly

| PRJNA826307 | ENA

Allorhizobium taibaishanense strain:14971

Project description:Allorhizobium taibaishanense strain:14971 Genome sequencing and assembly

| PRJNA344720 | ENA

Allorhizobium pseudoryzae strain:DSM 19479

Project description:Allorhizobium pseudoryzae strain:DSM 19479 Genome sequencing

| PRJNA608222 | ENA

Allorhizobium terrae strain:CC-HIH110

Project description:Allorhizobium terrae strain:CC-HIH110 Genome sequencing and assembly

| PRJNA531785 | ENA

Allorhizobium undicola ORS 992 = ATCC 700741

Project description:Allorhizobium undicola ORS 992 = ATCC 700741 Genome sequencing and assembly

| PRJNA223117 | ENA

Allorhizobium undicola ORS 992 = ATCC 700741

Project description:Allorhizobium undicola ORS 992 = ATCC 700741 Variation

| PRJNA213189 | ENA

Project description:Genome sequencing of Allorhizobium

| PRJNA1171486 | ENA

Project description:Allorhizobium vitis strains genome sequencing

| PRJNA557463 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Allorhizobium taibaishanense

Project description:Rhizobium taibaishanense overview

| PRJNA344810 | ENA